Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease

NCT03899246 is registered in ClinicalTrials.gov with Children's Hospital of Michigan as lead sponsor.

NCT NCT03899246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease
Lead sponsor
Children's Hospital of Michigan
Phase
Phase 1
Overall status
Completed
Start date
July 3, 2019
Completion date
March 30, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain, sickle cell disease